Sterling Capital Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Sterling Capital Management's DFTX Position: Q3 2026 in Review
Sterling Capital Management increased its Definium Therapeutics (DFTX) stake by 803% in Q3 2026, buying an estimated $155K and bringing the position to 4,128 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #1236.
Sterling Capital Management first reported a position in DFTX in Q3 2024 and has held it in 9 quarters since. 302 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Sterling Capital Management held 4,128 shares of Definium Therapeutics worth $157K as of Q3 2026.
- Sterling Capital Management bought 3,671 Definium Therapeutics shares in Q3 2026, an estimated $155K.
- Definium Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1236 holding.
- Sterling Capital Management first reported a position in Definium Therapeutics in Q3 2024 and has held it in 9 quarters since.
- 302 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.